Literature DB >> 16945612

Laryngeal cancer and gastroesophageal reflux disease: a case-control study.

Michael F Vaezi1, Mohammed A Qadeer, Rocio Lopez, Natalie Colabianchi.   

Abstract

PURPOSE: Gastroesophageal reflux disease (GERD) is common in patients with laryngeal cancer. However, the role of GERD in laryngeal cancer remains controversial because of poor matching and selection of inappropriate control groups in prior studies. We aimed to better understand this relationship by conducting a matched case-control study.
METHODS: This study was based in a single tertiary care center over a 2-year period. Cases included all patients with a diagnosis of new laryngeal cancer presenting to the otolaryngology clinics. Two controls, derived from the internal medicine clinics, were matched to the cases on an individual basis for age (within 1 year), gender, ethnicity, and time of first visit to the institution (within 1 month). Data were extracted by chart review. Conditional logistic regression was used to assess the relationship between laryngeal cancer and GERD, tobacco, and alcohol consumption.
RESULTS: A total of 96 cases were matched to 192 controls. On univariable analysis, the significant risk factors were current smoking, odds ratio (OR) 5.46 (95% confidence interval [CI], 2.59-11.50); alcohol, OR 1.97 (CI, 1.19-3.26); and GERD, OR 1.79 (CI, 1.03-3.11). On multivariable analysis, only smoking and GERD continued to be significantly associated with laryngeal cancer, OR 6.08 (CI, 2.82-13.10) and OR 2.11 (CI, 1.16-3.85), respectively.
CONCLUSIONS: Smoking and GERD are significant risk factors for laryngeal cancer and may have an independent incremental risk for laryngeal carcinogenesis.

Entities:  

Mesh:

Year:  2006        PMID: 16945612     DOI: 10.1016/j.amjmed.2006.01.019

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  20 in total

1.  Optimal treatment of laryngopharyngeal reflux disease.

Authors:  Irene Martinucci; Nicola de Bortoli; Edoardo Savarino; Andrea Nacci; Salvatore Osvaldo Romeo; Massimo Bellini; Vincenzo Savarino; Bruno Fattori; Santino Marchi
Journal:  Ther Adv Chronic Dis       Date:  2013-11       Impact factor: 5.091

2.  Predictive factors of recurrence and malignant transformation in vocal cord leukoplakia.

Authors:  Dong Hoon Lee; Tae Mi Yoon; Joon Kyoo Lee; Sang Chul Lim
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-03-08       Impact factor: 2.503

3.  Laryngopharyngeal Reflux and Functional Laryngeal Disorder: Perspective and Common Practice of the General Gastroenterologist.

Authors:  Dhyanesh A Patel; Michael Blanco; Michael F Vaezi
Journal:  Gastroenterol Hepatol (N Y)       Date:  2018-09

Review 4.  Gastroesophageal reflux disease and non-esophageal cancer.

Authors:  Fernando A M Herbella; Sebastião Pannocchia Neto; Ilka Lopes Santoro; Licia Caldas Figueiredo
Journal:  World J Gastroenterol       Date:  2015-01-21       Impact factor: 5.742

5.  How much pharyngeal exposure is "normal"? Normative data for laryngopharyngeal reflux events using hypopharyngeal multichannel intraluminal impedance (HMII).

Authors:  Toshitaka Hoppo; Alejandro F Sanz; Katie S Nason; Thomas L Carroll; Clark Rosen; Daniel P Normolle; Nicholas J Shaheen; James D Luketich; Blair A Jobe
Journal:  J Gastrointest Surg       Date:  2011-10-28       Impact factor: 3.452

6.  Characteristics of cigarette smoking without alcohol consumption and laryngeal cancer: overall and time-risk relation. A meta-analysis of observational studies.

Authors:  Jing-Jing Zuo; Ze-Zhang Tao; Chen Chen; Zhang-Wei Hu; Ye-Xing Xu; An-Yuan Zheng; Yi Guo
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-11-14       Impact factor: 2.503

7.  [Perceptual and automatic voice and speech analysis of chronic laryngitis and T1 vocal cord cancer].

Authors:  B Bartke; T Haderlein; M Döllinger; E Nöth; S Graf; U Eysholdt; A Ziethe
Journal:  HNO       Date:  2013-08       Impact factor: 1.284

8.  Gastric reflux is an independent risk factor for laryngopharyngeal carcinoma.

Authors:  Scott M Langevin; Dominique S Michaud; Carmen J Marsit; Heather H Nelson; Ariel E Birnbaum; Melissa Eliot; Brock C Christensen; Michael D McClean; Karl T Kelsey
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-05-23       Impact factor: 4.254

Review 9.  Physical activity and laryngeal cancer.

Authors:  Riccardo Nocini; Fabian Sanchis-Gomar; Giuseppe Lippi
Journal:  Ann Transl Med       Date:  2019-12

10.  The mucosal immune response to laryngopharyngeal reflux.

Authors:  Louisa E N Rees; Laszlo Pazmany; Danuta Gutowska-Owsiak; Charlotte F Inman; Anne Phillips; Christopher R Stokes; Nikki Johnston; Jamie A Koufman; Gregory Postma; Michael Bailey; Martin A Birchall
Journal:  Am J Respir Crit Care Med       Date:  2008-03-06       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.